The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksQFI.L Regulatory News (QFI)

  • There is currently no data for QFI

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Kuwait Services Agreement & Grant of Warrants

26 Feb 2019 07:00

RNS Number : 0673R
Quadrise Fuels International PLC
26 February 2019
 

 

Quadrise Fuels International plc

("Quadrise", "QFI" or the "Company")

 

Kuwait Services Agreement with Conditional Grant of Warrants

 

Quadrise is pleased to announce that the Company has entered into a Services Agreement ("SA") with Aleph Commodities Ltd ("Aleph") to pursue opportunities on behalf of Quadrise for the use of MSAR® in Kuwait.

 

Aleph is a UK company that has been established recently by a small group of commodities traders with significant experience in the Middle East.

 

The SA provides Aleph with a success-based incentive structure, with rewards only due upon delivering relevant disclosable project milestones and contracts that lead to the establishment of MSAR® projects and commercial sales in Kuwait.

 

The SA also provides that Aleph may be awarded up to a total of 40 million warrants over ordinary shares in the Company, provided certain key milestones are achieved.

 

· The first tranche of 5 million warrants will be awarded upon signature, during 2019, of a disclosable project milestone in relation to the conclusion of a relationship with a local partner in Kuwait and will be exercisable for a period of 2 years from the date of the SA.

 

· The second tranche of 10 million warrants will be awarded upon signature, during 2019, of a disclosable project milestone enabling a commercial MSAR® trial or study in Kuwait and will be exercisable for a period of 3 years from the date of the SA.

 

· The third tranche of 25 million warrants will be awarded upon signature of contracts for a commercial MSAR® project in Kuwait and will be exercisable for a period of 4 years from the date of the SA.

 

All of the above warrants will have an exercise price of the average mid-market closing price over five days, ending on and including the day after QFI publicly announces signature of the relevant project milestones and contracts.

 

Under the SA, royalties will be payable to Aleph from any project for the supply and use of MSAR® in Kuwait introduced via Aleph. The SA is evergreen, unless terminated by mutual agreement with one month's notice.

 

Kuwait is a country covered under the Co-Marketing and Project Development Agreement ("CMPDA") with Freepoint Commodities LLC ("Freepoint") announced by Quadrise on 30 November 2018. Any project delivered in Kuwait will therefore be subject to the terms of the CMPDA.

Commenting on this development Mike Kirk, Executive Chairman of QFI, said:

"Entering into this services agreement with Aleph is an important milestone for Quadrise in the Middle East.

Kuwait is a market in which we have undertaken substantial work over the past 18 months and where we have made good progress to establish a firm understanding of our technology in country. Quadrise's engagement in Kuwait will continue to be coordinated with Freepoint in connection with the CMPDA announced last November, and such engagement will now be enhanced by our new relationship with Aleph.  We believe Aleph's strong relationships in the Middle East, and Kuwait in particular, will be instrumental in enabling practical delivery of domestic MSAR® projects.

The reward structure that we have put in place, puts the focus on near-term delivery during 2019 and aligns all parties to project delivery and the creation of significant shareholder value."

 

 

For further information, please refer to the Company's website at www.quadrisefuels.com, or contact ir@quadrisefuels.com or phone:

 

Quadrise Fuels International Plc

Mike Kirk, Executive Chairman

+44 (0)20 7031 7321

Jason Miles, Chief Operating Officer

Nominated Adviser

Cenkos Securities plc

Dr Azhic Basirov

+44 (0)20 7397 8900

Ben Jeynes

Katy Birkin

Joint Brokers

Peel Hunt LLP

Richard Crichton

+44 (0)20 7418 8900

Ross Allister 

Stockdale Securities

Andy Crossley

Daniel Harris

+44 (0)20 7601 6108

 

Public & Investor Relations

FTI Consulting

Ben Brewerton

+44 (0)20 3727 1000

Sara Powell

 

For further information about Freepoint, please refer to Freepoint's website at www.freepoint.com.

 

Notes to Editors

 

QFI is the supplier of MSAR® emulsion technology and fuels, a low-cost alternative to heavy fuel oil (one of the world's largest fuel markets, comprising over 450 million tons per annum) in the global power generation, shipping, steam and refining industries.

 

This announcement is inside information for the purposes of Article 7 of EU Regulation 596/2014.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
AGRDELFLKLFEBBB
Date   Source Headline
13th Mar 20237:00 amRNSProposed Change of Name
6th Mar 20234:35 pmRNSPrice Monitoring Extension
3rd Mar 20237:00 amRNSWärtsilä Testing Update
2nd Mar 20234:35 pmRNSPrice Monitoring Extension
23rd Feb 20237:00 amRNSMorocco Project Update
1st Feb 20237:00 amRNSBlock Admission Cancellation and Interim Review
31st Jan 20237:00 amRNSAppointment of New Auditor
30th Jan 20237:00 amRNSRe-Issue of Historical Share Options
16th Jan 20237:00 amRNSBusiness Update
29th Nov 20222:23 pmEQSQuadrise Fuels International (QFI): Key role in transitioning to net-zero
25th Nov 20222:16 pmRNSResult of AGM
25th Nov 20227:00 amRNSAGM Statement
23rd Nov 20227:00 amRNSPublication of Sustainability Report
15th Nov 20227:00 amRNSExtension of Exclusive Agreement with Nouryon
28th Oct 20224:48 pmRNSPosting of Annual Report and Notice of AGM
3rd Oct 20227:00 amRNSFinal Results and Notice of AGM
21st Sep 20227:00 amRNSJoint Development Agreement with Vertoro
14th Sep 20227:00 amRNSNotice of Results and Investor Presentation
4th Aug 20227:00 amRNSIssue of Share Options and Director/PDMR Dealing
1st Aug 202210:52 amRNSDirector/PDMR Dealing
1st Aug 20229:30 amRNSBlock Admission Interim Review
27th Jul 20227:00 amRNSFramework Agreement with MSC Shipmanagement
21st Jul 20224:41 pmRNSSecond Price Monitoring Extn
21st Jul 20224:35 pmRNSPrice Monitoring Extension
15th Jul 20225:40 pmRNSHolding(s) in Company
16th Jun 20227:00 amRNSIssue of Warrants
13th Jun 20227:30 amRNSMaterial Transfer & Cooperation Agreement
13th Jun 20227:00 amRNSAddendum to Representation Agreement
9th May 20227:00 amRNSOperational Update
22nd Apr 20224:40 pmRNSSecond Price Monitoring Extn
22nd Apr 20224:35 pmRNSPrice Monitoring Extension
11th Apr 20224:41 pmRNSSecond Price Monitoring Extn
11th Apr 20224:35 pmRNSPrice Monitoring Extension
11th Apr 20228:28 amRNSCommercial Development Agreement with Valkor
28th Mar 20227:00 amRNSInterim Results
1st Feb 20223:00 pmRNSBlock Admission Interim Review
1st Feb 20228:44 amRNSReplacement:Appointment of Non-Executive Chairman
1st Feb 20227:00 amRNSAppointment of Non-Executive Chairman
31st Jan 20227:00 amRNSUpdate re bioMSAR Testing at Aquafuel Research Ltd
27th Jan 202211:57 amRNSHolding(s) in Company
17th Jan 20224:41 pmRNSSecond Price Monitoring Extn
17th Jan 20224:35 pmRNSPrice Monitoring Extension
6th Jan 20224:41 pmRNSSecond Price Monitoring Extn
6th Jan 20224:36 pmRNSPrice Monitoring Extension
4th Jan 20227:00 amRNSAppointment of Chief Operating Officer
29th Dec 20214:42 pmRNSSecond Price Monitoring Extn
29th Dec 20214:36 pmRNSPrice Monitoring Extension
21st Dec 20214:41 pmRNSSecond Price Monitoring Extn
21st Dec 20214:36 pmRNSPrice Monitoring Extension
15th Dec 20215:05 pmRNSChange of Adviser

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.